Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy DrugsEnric Monreal, Luisa María Villar, Roberto Álvarez‐Lafuente et al.|JAMA Neurology|2023Cited by 51
Serum biomarkers at disease onset for personalized therapy in multiple sclerosisEnric Monreal, Luisa María Villar, José Ignacio Fernández-Velasco et al.|Brain|2024Cited by 44